These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 24581962

  • 1. Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation?
    Zheng JS, Long J, Sun B, Lu NN, Fang D, Zhao LY, Du N.
    Clin Radiol; 2014 Jun; 69(6):e253-63. PubMed ID: 24581962
    [Abstract] [Full Text] [Related]

  • 2. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J, Zheng JS, Sun B, Lu N.
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J, Zheng JP, Shao GL, Wen S, Guo LW, Zeng H, Zhang L, Qian CY, Hao WY.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr 20; 26(4):298-304. PubMed ID: 29996343
    [Abstract] [Full Text] [Related]

  • 5. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO, Kim BS, Lee CH.
    Clin Mol Hepatol; 2016 Mar 20; 22(1):160-7. PubMed ID: 27044767
    [Abstract] [Full Text] [Related]

  • 6. Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
    Wang J, Li X, Wang F, Shi D, Zhang J.
    J Cancer Res Ther; 2021 Jul 20; 17(3):619-624. PubMed ID: 34269290
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
    Tan X, Xie P, Liu J, Wu H, Xie Y.
    Asia Pac J Clin Oncol; 2015 Sep 20; 11(3):e6-e12. PubMed ID: 25228074
    [Abstract] [Full Text] [Related]

  • 8. Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization.
    Shirai S, Sato M, Suwa K, Kishi K, Shimono C, Sonomura T, Kawai N, Tanihata H, Minamiguchi H, Nakai M.
    Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1037-44. PubMed ID: 19540053
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus.
    Pan T, Li XS, Xie QK, Wang JP, Li W, Wu PH, Zhao M.
    Clin Radiol; 2014 Dec 15; 69(12):e553-61. PubMed ID: 25304928
    [Abstract] [Full Text] [Related]

  • 10. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.
    J Gastroenterol Hepatol; 2016 Feb 15; 31(2):442-9. PubMed ID: 26259976
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF.
    World J Gastroenterol; 2014 Dec 14; 20(46):17483-90. PubMed ID: 25516662
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, Chung YH, Lee YS, Lee SG, Park JH, Suh DJ.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):2004-11. PubMed ID: 21621346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria.
    Liu H, Wang ZG, Fu SY, Li AJ, Pan ZY, Zhou WP, Lau WY, Wu MC.
    Br J Surg; 2016 Mar 01; 103(4):348-56. PubMed ID: 26780107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.